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Presentation of the MIPFE checklist 
A proposal for the introduction of the Minimal 
Information (MI) platform dedicated to the 
acquisition and annotation of data concerning 
recombinant proteins (Minimal Information for 
Protein Functionality Evaluation –  MIPFE) was 
recently published [1] and discussed at the 5th 
Recombinant Protein Production Conference 
(Alghero 2008) and the 2009 PEP Talk meeting (San 
Diego). The benefits of such standards are generally 
recognized, although there are concerns regarding 
its implementation as well as its perception of being 
too invasive for research freedom [2]. 
The meaning attributed to stored data is 
perceived differently within the MI community. 
The necessity of optimizing the quality of protein 
quality data annotation is generally acknowledged 
[3,4], since ontology and formal correctness are 
crucial for unambiguous data reporting and 
comparison, and ignoring such rules would 
decrease the accuracy of curation, lead to the loss 
of valuable information for efficient data mining 
and prevent the assessment of the experimental 
methods [5]. However, in certain domains further 
orthogonal corroboration of the same material 
used in reported experiments is highly desired for 
the identification and recognition of artifacts and 
assessment of the final results. For instance, it is 
still very often the case that published biological 
data are obtained with starting material, the 
structural characteristics of which have not been 
evaluated or made available [6]. As a result, there 
is a pressing need for good practice guidelines 
within publications and databases, as for example 
in the evaluation of the native state of proteins 
used for in vitro interaction assays [1,7]. Recombinant protein quality evaluation 
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The reputation of journals, as well as funding bodies, 
depends on data quality. However, data quality is 
often hard to evaluate during the peer-review 
process. This has not gone unnoticed in the editorial 
context, where, for example, improvements to the 
peer-review process have been suggested that will 
facilitate the collection, submission and validation of 
proteomic, microarray and, more recently, imaging 
data [8]. In addition, funding agencies are becoming 
increasingly concerned about the reliability  and 
accessibility of data collected by laboratories which 
they fund [8-10]. We therefore argue that it is time 
to implement similar policies for the transparent 
and rigorous reporting of data in all publications 
concerning proteins. For example, it is often ignored 
that recombinant proteins form not only insoluble 
precipitates, but also soluble aggregates, mostly 
when carriers are fused to improve solubility [11-
13]. Such aggregates may retain some function 
[13,14] and therefore, without controlled 
experiments aimed at defining monodispersity and 
native structure, the interpretation of experimental 
results is weakened. Thus, the scientific community 
(editors, reviewers, readers) must have access to the 
raw data to assess the biophysical characterization 
and, accordingly, be able to judge the quality of the 
proteins used in the experiments. Ideally, it will 
remain the responsibility of editors and referees to 
check the robustness of controls and, where 
necessary, to request further experiments using the 
original material. Integration of annotated control 
experiments into the main text offers a useful 
complementary evaluation tool for reviewers and 
readers. We consider that information concerning 
aggregation status and secondary structure should 
be reported as a minimal requirement for 
publication under Supplementary Material. These 
controls should be available when authors describe 
protein production as well as protein interaction 
experiments (pull-down, surface plasmon resonance, 
antibody/protein microarrays, and isothermal 
titration calorimetry). 
In practice, it is important to define what is to be 
considered mandatory and what may remain 
optional within the MI package. An overly rigid and 
demanding protocol will be perceived as 
interference in the scientific work and most likely 
would be rejected by the community on these 
grounds. Recently, an interesting attempt at 
identifying a version of the MI guideline for 
describing proteins interacting in complexes has 
been reported [15]. However, it is difficult to judge 
the efficacy of the approach since the number of 
participants who volunteered to deposit the 
required information was limited to five. 
In order to offer a workable solution for describing 
the MI for the evaluation of recombinant protein 
quality we propose a solution involving a repository 
to store the relevant results concerning protein 
construct features and biophysical characterization. 
Uploading of the information into the database is 
available through the MIPFE site [16]. We have 
designed a loosely structured text form allowing 
authors to describe the minimal information from an 
experiment which can be made available to 
reviewers, editors, and ultimately to other scientists. 
The proposed format requires little effort by the 
user (e.g. cut and paste using a simple text editor on 
any computing platform), and is human readable, 
yet sufficiently structured and formatted to allow 
data meta-analysis. Non-textual experimental 
results, such as gels and graphs, can be uploaded as 
image files alongside the form.  In addition to its 
simplicity, the form can be copied and re-used by the 
authors and indeed the scientific community. Once 
deposited and validated, the dataset is given a 
unique handle which can be referred to in published 
manuscripts (for instance, as Supplementary 
Material), and possibly as a DOI tagged entity, as 
suggested recently [17]. 
Only the essential amount of obligatory information 
concerning the construct must be provided by the 
authors in the MIPFE form, in order to avoid 
possible misinterpretation  of any annotation 
[18,19]. The fields concerning characterization 
experiments remain optional and are intended as 
guidelines for controlled experiments that are run in 
order to evaluate protein structural quality. 
Although our approach is designed to capture the 
minimal amount of data from the user as quickly and 
effortlessly as possible, the form does allow for raw 
data to be described and deposited, encouraging 
users to provide as complete an entry as possible. MI 
platforms evolve progressively to match needs and 
overcome limitations [20] and the logical future 
development of the one we propose could be the 
implementation of the MIBBI standardization 
guidelines for annotation [21,22], allowing more 
extensive annotation and ultimately data mining and 
bioinformatic analyses. Buckle et al. 
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